Despite these technical and regulatory hurdles, interest in the company’s advancements remains high, with over 1,000 human volunteers signed up for its second round of surgical trials.
Musk stated that Neuralink intends to implant up to eight more patients with its Telepathy technology by the end of 2024.
There is growing interest in the technologies Musk has pioneered.
Testing in Monkeys
According to Musk, Telepathy has already demonstrated functionality in monkeys. This achievement is significant, although it has raised some concerns.
Neuralink animal testing practices have reportedly drawn scrutiny from federal investigators, but Musk maintains that “no monkey has died or been seriously injured by a Neuralink device.”
Blindsight and Telepathy reflect Elon Musk’s ambitious vision for neurotechnology, but the road ahead is complex.
While the FDA’s designation is a promising step, the company must address regulatory, technical, and ethical issues as it seeks to bring these devices to the public.
